MEDSIR presents the results of three new studies at ESMO 2023: LUPER, focusing on lung cancer, and two translational studies of PHERGain in breast cancer ...Middle East

MADRID, Oct. 21, 2023 /PRNewswire/ -- MEDSIR, a company specializing in the strategic design of independent clinical research, today presented the results of three new studies at the European Society for Medical Oncology (ESMO 2023), one of the most prestigious oncology platforms for...

Hence then, the article about medsir presents the results of three new studies at esmo 2023 luper focusing on lung cancer and two translational studies of phergain in breast cancer was published today ( Saturday 21/10/2023 - 04:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MEDSIR presents the results of three new studies at ESMO 2023: LUPER, focusing on lung cancer, and two translational studies of PHERGain in breast cancer )

Also on site :

• Descendants: Wicked Wonderland Team Breaks Down The Movie's Mysterious Ending: 'We Shot It A Number Of Different Ways'
• ‘Age of Attraction’ Is Netflix’s Top New Reality Launch, But ‘Star Search’ & ‘Calabasas Confidential’ Struggle
• PVR Inox’s Sanjeev Kumar Bijli On India’s Box Office Recovery, Cinema Expansion & Cannes Acquisitions Haul